Roxatidine Acetate HClCAS# 93793-83-0 |
- Perindopril Erbumine
Catalog No.:BCC3586
CAS No.:107133-36-8
- Losartan Potassium (DuP 753)
Catalog No.:BCC1080
CAS No.:124750-99-8
- Candesartan
Catalog No.:BCC2558
CAS No.:139481-59-7
- Telmisattan
Catalog No.:BCC3863
CAS No.:144701-48-4
- Imidapril HCl
Catalog No.:BCC3792
CAS No.:89396-94-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 93793-83-0 | SDF | Download SDF |
PubChem ID | 56704 | Appearance | Powder |
Formula | C19H29ClN2O4 | M.Wt | 384.9 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 50 mg/mL (129.90 mM; Need ultrasonic) H2O : ≥ 50 mg/mL (129.90 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate;hydrochloride | ||
SMILES | [H+].[Cl-].CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1 | ||
Standard InChIKey | FEWCTJHCXOHWNL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H28N2O4.ClH/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21;/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23);1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Roxatidine Acetate HCl Dilution Calculator
Roxatidine Acetate HCl Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5981 mL | 12.9904 mL | 25.9808 mL | 51.9615 mL | 64.9519 mL |
5 mM | 0.5196 mL | 2.5981 mL | 5.1962 mL | 10.3923 mL | 12.9904 mL |
10 mM | 0.2598 mL | 1.299 mL | 2.5981 mL | 5.1962 mL | 6.4952 mL |
50 mM | 0.052 mL | 0.2598 mL | 0.5196 mL | 1.0392 mL | 1.299 mL |
100 mM | 0.026 mL | 0.1299 mL | 0.2598 mL | 0.5196 mL | 0.6495 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Roxatidine Acetate HCl is a specific and competitive histamin H2 receptor antagonist.
- gamma-Secretase Modulators
Catalog No.:BCC1586
CAS No.:937812-80-1
- Neurodazine
Catalog No.:BCC7738
CAS No.:937807-66-4
- Neogambogic acid
Catalog No.:BCN2321
CAS No.:93772-31-7
- Jangomolide
Catalog No.:BCN4483
CAS No.:93767-25-0
- GRP (human)
Catalog No.:BCC5810
CAS No.:93755-85-2
- Magnaldehyde D
Catalog No.:BCN4070
CAS No.:93753-33-4
- Pacritinib (SB1518)
Catalog No.:BCC4558
CAS No.:937272-79-2
- SB1317
Catalog No.:BCC1925
CAS No.:937270-47-8
- ARRY-380
Catalog No.:BCC3726
CAS No.:937265-83-3
- NSC 95397
Catalog No.:BCC7109
CAS No.:93718-83-3
- GSK690693
Catalog No.:BCC2483
CAS No.:937174-76-0
- Leuconolam
Catalog No.:BCN4482
CAS No.:93710-27-1
- 3-Prenyl-2,4,6-trihydroxybenzophenone
Catalog No.:BCN1303
CAS No.:93796-20-4
- 22-beta-Acetoxyglycyrrhizin
Catalog No.:BCN7904
CAS No.:938042-17-2
- ATPγS tetralithium salt
Catalog No.:BCC7855
CAS No.:93839-89-5
- KU-0063794
Catalog No.:BCC2484
CAS No.:938440-64-3
- Isochamaejasmine
Catalog No.:BCN3128
CAS No.:93859-63-3
- 9-Oxo-2,7-bisaboladien-15-oic acid
Catalog No.:BCN4484
CAS No.:93888-59-6
- FIPI
Catalog No.:BCC7721
CAS No.:939055-18-2
- Hirsutanonol 5-O-glucoside
Catalog No.:BCN4485
CAS No.:93915-36-7
- Toonaciliatin M
Catalog No.:BCN7881
CAS No.:93930-04-2
- Fluvastatin
Catalog No.:BCC1579
CAS No.:93957-54-1
- Fluvastatin Sodium
Catalog No.:BCC2317
CAS No.:93957-55-2
- [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
Catalog No.:BCC5719
CAS No.:93965-89-0
Cytoprotective action of roxatidine acetate HCl.[Pubmed:2906796]
Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:295-304.
The cytoprotective action of Roxatidine Acetate HCl (roxatidine) was investigated. We also studied the involvement of endogenous prostaglandins (PGs) in the cytoprotective action of roxatidine and the effect of roxatidine on SRS content in pleurisy induced by A23187. Simultaneously, these effects of roxatidine were compared with those of other histamine H2-receptor antagonists at the same anti-secretory activity level. Roxatidine prevented formation of the gastric mucosal lesions induced by abs. ethanol, 0.6 N HCl and 0.2 N NaOH, but it failed to prevent 30% NaCl-induced gastric mucosal lesions. Cimetidine, ranitidine and famotidine failed to prevent formation of the gastric mucosal lesions induced by necrotizing agents. The cytoprotective action of roxatidine was not abolished by pretreatment with indomethacin. Roxatidine did not greatly influence SRS production. Consequently, it appears that roxatidine has a cytoprotective action and that this action is not associated with endogenous PGs and SRS.